Sclerotherapy is a popular method of eliminating varicose veins and superficial telangioectasis (spider veins) in which a solution, called a sclerosing agent, is injected into the veins.
The majority of persons who have sclerotherapy performed will be cleared of their varicosities or at least see good improvement. Unfortunately, however, there is no guarantee that sclerotherapy will be effective in every case. Approximately 10% of patients who undergo sclerotherapy have poor to fair results. ("Poor results" means that the veins have not totally disappeared after six treatments.) In very rare instances, the patient's condition may become worse after sclerotherapy treatment.
The number of treatments needed to clear or improve the condition differs from patient to patient, depending on the extent of varicose and spider veins present. One to six or more treatments may be needed; the average is three to four. Individual veins usually require one to three treatments.
The most common side effects experienced with sclerotherapy treatments are
Other, less common, side effects include a burning sensation during injection of some solutions, neovascularization (the development, usually temporary, of new, tiny blood vessels), transient phlebitis-type reactions (swelling of the vein) which might cause the ankles to swell, temporary superficial blebs or wheals (similar to hives), and, very rarely, wound infections, poor healing, or scarring.
Rare complications of sclerotherapy include visual disturbances and transient ischaemic attacks or stroke.
Phlebitis is a very rare complication, seen in approximately one out of every 1000 patients treated for varicose veins which are greater than 3 to 4 mm. in diameter.
The dangers of phlebitis include the possibility of pulmonary embolus (a blood clot to the lungs) which may result in permanent lung damage or death, and post-phlebitis syndrome, in which the blood clot is not carried out of the lungs, resulting in permanent swelling of the legs.
In most cases of large varicose veins (greater than 3 to 4 mm. in diameter), spontaneous phlebitis and/or thrombosis (blood clot) may occur. Additionally, large skin ulcerations may develop in the ankle region of patients who have long-standing varicose veins with underlying venous insufficiency. Rarely, those ulcers may hemorrhage or become cancerous.
VNUS Closure may also be used to treat varicose veins, but not telangiectasias. The VNSU Closure procedure requires outpatient surgery and is performed while the patient is under local anesthesia and sedation. This type of surgery is usually reserved for patients with large varicose veins not amenable to sclerotherapy or patients with significant incompetence of their greater saphenous vein. Sometimes a combination of surgery and sclerotherapy is required.
If you notice any type of adverse reaction, please call our office immediately: 617.244.5355.
Hernia | Breast
Diverticulitis | Colon | Gallbladder | Hiatal hernia
Vascular surgery | VNUS Closure | General
Hernia | Pilonidal disease| Gallbladder | Appendix |
Colon and rectal cancer | Diverticulitis | Anorectal | Inflammatory bowel disease
Thyroid & Parathyroid|Adrenal|Melanoma|Breast